Novacyt hails progress on Covid-19 testing efforts


Paris-based diagnostics group Novacyt said Queen Mary University of London had completed clinical trial using its rapid testing platforms for Covid-19 in care homes.

Over 4,500 samples and subsequent results had been recorded, with data analysis underway and results expected in the second half of 2021.

The update was part of a broader review of Novacyt's research and development activities, including an expansion of its Covid-19 portfolio.

'Novacyt remains focused on leveraging its innovative reputation and position in the rapidly changing Covid-19 testing market to continue to deliver value and support clinicians and laboratories in a global setting,' chief executive Graham Mullis said.

'Of note, following its launch, our PROmate test has been well received by users and opens up new opportunities for rapid PCR testing, including in private testing markets.'

'In addition, we look forward to presenting exciting long-term plans for Novacyt during the second quarter of this year as we continue to define our strategy for delivering sustainable, long- term growth.'

At 8:50am: (LON:NCYT) Novacyt S.A. share price was 0p at 897p

Related content

Novacyt shock means investors should get out now


A profit warning on 9 April from specialist clinical diagnostics firm Novacyt (NCYT:AIM) is a major turning point for how we view the stock....

Thu, 15/04/2021 - 00:00

The best performing stocks of 2020

After an extraordinary year we look back at some of the top performers in different size categories from the heavyweights all the way down to...

Wed, 23/12/2020 - 00:00

GlaxoSmithKline vaccine delay and Novacyt's new virus strain test


GlaxoSmithKline (GSK) £14.00

Gain to date: 6%
Original entry point: Buy at £13.21, 5 November 2020

Novacyt (NCYT:AIM) 870.2p


Thu, 17/12/2020 - 00:00

The big rotation into value


Value investors often say there is no point trying to time the rotation back to their value style because it can happen in the blink...

Thu, 19/11/2020 - 00:00

Novacyt hails positive UK trial data for Covid-19 test

Paris-based diagnostics group Novacyt said encouraging interim data had been reported from an ongoing clinical trial in care homes that was assessing the accuracy of...

Mon, 16/11/2020 - 09:36